Filing Flows › Agape ATP (ATPC) › Q2 2026
Agape ATP (ATPC) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
Agape ATP (ATPC) reported revenue of $109K for the second quarter 2026 (Q2 2026), -77% from a year earlier and -60% from the quarter before. Operating margin was -505.0%, net earnings $153K (140.2% of revenue).
Agape ATP, Q2 2026: revenue $109K (-77% year over year), operating margin -505.0%, net earnings $153K, operating cash flow −$110K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $109K | -60% | -77% |
| Operating profit | −$551K | — | — |
| Net earnings | $153K | — | — |
| Operating cash flow | −$110K | — | — |
What changed
Revenue was $109K in Q2 2026, down 77% year over year and down 60% from the previous quarter. Health and Wellness Services was the largest line at 73% of revenue. Product Health Therapies lost $203K year over year (down 93%), 57% of the total change.
Gross margin was 10.8%, down 3.3 points from Q2 2025. Operating costs exceeded revenue by $551K, an operating margin of -505.0%. Operating expenses fell 18% while revenue fell 77%. Net earnings were $149K. The effective tax rate was -83.0%. Non-operating items added $635K, 759% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$110K. Working capital and other items used $263K.
Questions
What was Agape ATP's revenue in the second quarter 2026?
Agape ATP (ATPC) reported revenue of $109K for the second quarter 2026 (Q2 2026), -77% from a year earlier and -60% from the quarter before.
Was Agape ATP profitable in the second quarter 2026?
Operating loss was $551K (-505.0% of revenue) and net earnings $153K.
Source: Agape ATP 10-Q on SEC EDGAR.